1. Home
  2. TPCS vs ANEB Comparison

TPCS vs ANEB Comparison

Compare TPCS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

HOLD

Current Price

$4.66

Market Cap

40.9M

Sector

Industrials

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$1.20

Market Cap

96.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPCS
ANEB
Founded
1956
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.9M
96.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TPCS
ANEB
Price
$4.66
$1.20
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
103.1K
Earning Date
11-13-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,564,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.15
N/A
52 Week Low
$2.05
$0.90
52 Week High
$6.25
$3.42

Technical Indicators

Market Signals
Indicator
TPCS
ANEB
Relative Strength Index (RSI) 54.23 19.72
Support Level $4.24 $1.14
Resistance Level $4.74 $2.40
Average True Range (ATR) 0.26 0.19
MACD 0.04 -0.11
Stochastic Oscillator 76.14 4.77

Price Performance

Historical Comparison
TPCS
ANEB

About TPCS TechPrecision Corporation

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: